Change search
Link to record
Permanent link

Direct link
Jakobsson, Niklas, ProfessorORCID iD iconorcid.org/0000-0002-7143-8793
Publications (10 of 67) Show all publications
Johansson, N., Jakobsson, N. & Svensson, M. (2024). Place or patient as the driver of regional variation in healthcare spending – Discrepancies by category of care. Social Science and Medicine, 342, Article ID 116571.
Open this publication in new window or tab >>Place or patient as the driver of regional variation in healthcare spending – Discrepancies by category of care
2024 (English)In: Social Science and Medicine, ISSN 0277-9536, E-ISSN 1873-5347, Vol. 342, article id 116571Article in journal (Refereed) Published
Abstract [en]

We study how much regional variation in healthcare spending is driven by place- and patient-specific factors using a random sample of 53,620 regional migrants in Sweden. We find notable differences depending on the category of care, with place-specific factors having a significantly larger impact on specialized outpatient care compared to inpatient and pharmaceutical care. The place effect is estimated to 75% of variation in specialized outpatient care, but 26% or less in variations in inpatient care, and 5% in prescription drug spending. We also find that the empirical estimator has a substantial impact on the estimates of the place-specific effect. The results based on the traditional approach in the literature with two-way fixed effects and event-study models produce much larger estimates of the place-specific effect compared to results based on recently developed heterogeneity-robust models. For total healthcare spending, the traditional two-way fixed effects model estimates a place effect of 78%, while the heterogeneity-robust estimator finds a place effect around 10%. This finding indicates that previous results in this literature, all based on traditional two-way fixed-effects regressions, should be interpreted with care. 

Place, publisher, year, edition, pages
Elsevier, 2024
Keywords
Healthcare spending, Regional variation, Movers, Event study, Two-way fixed effects
National Category
Health Care Service and Management, Health Policy and Services and Health Economy Public Health, Global Health, Social Medicine and Epidemiology
Research subject
Economics
Identifiers
urn:nbn:se:kau:diva-98341 (URN)10.1016/j.socscimed.2024.116571 (DOI)38215643 (PubMedID)2-s2.0-85182385969 (Scopus ID)
Funder
Swedish Research Council, 02708
Available from: 2024-02-02 Created: 2024-02-02 Last updated: 2024-02-02Bibliographically approved
Jakobsson, N. & Vikström, C. (Eds.). (2023). Bidrag från universitetspedagogisk konferens 2022. Karlstad: Karlstads universitet
Open this publication in new window or tab >>Bidrag från universitetspedagogisk konferens 2022
2023 (Swedish)Collection (editor) (Other academic)
Abstract [sv]

I föreliggande rapport kan du ta del av sju olika utvecklingsprojekt inom undervisning och examination vid Karlstads universitet. Samtliga bidrag i rapporten har utvecklats från projekt som presenterats vid enhetens universitetspedagogiska konferens.

I årets upplaga kan du bland annat läsa om en ny typ av tentamen, en klimatutmaning. Vad händer när studenter uppmanas att under en månads tid göra något annorlunda i sin vardag, så som att resa med cykel eller buss istället för bil? I en annan studie undersöker författarna huruvida det är någon skillnad för studenterna om läraren använder läsplatta eller dokumentkamera i inspelade föreläsningar.

Du får även en inblick i hur flexibla nätbaserade kurser för yrkesverksamma, i samverkan med företag och organisationer, kan bidra till det livslånga lärandet, och inte minst vilken roll sociala medier kan få när en kurs om vetenskaplig metod plötsligt ställs om till distans i pandemitider. 

Publicerade texter i rapportserien kan ligga till grund för pedagogisk meritering vid ansökan om att bli meriterad eller excellent inom undervisning och examination vid Karlstads universitet.

Place, publisher, year, edition, pages
Karlstad: Karlstads universitet, 2023. p. 107
Series
Utveckling av undervisning och examination i högre utbildning: utgiven av Universitetspedagogiska enheten vid Karlstads universitet ; 2023:1
National Category
Educational Sciences
Identifiers
urn:nbn:se:kau:diva-96765 (URN)978-91-7867-404-6 (ISBN)978-91-7867-405-3 (ISBN)
Available from: 2023-09-19 Created: 2023-09-19 Last updated: 2023-09-29Bibliographically approved
Chauca Strand, G., Johansson, N., Jakobsson, N., Bonander, C. & Svensson, M. (2023). Cancer Drugs Reimbursed with Limited Evidence on Overall Survival and Quality of Life: Do Follow-Up Studies Confirm Patient Benefits?. Clinical drug investigation, 43(8), 621-633
Open this publication in new window or tab >>Cancer Drugs Reimbursed with Limited Evidence on Overall Survival and Quality of Life: Do Follow-Up Studies Confirm Patient Benefits?
Show others...
2023 (English)In: Clinical drug investigation, ISSN 1173-2563, E-ISSN 1179-1918, Vol. 43, no 8, p. 621-633Article in journal (Refereed) Published
Abstract [en]

Background and ObjectiveCancer drug costs have increased considerably within healthcare systems, but many drugs lack quality-of-life (QoL) and overall survival (OS) data at the time of reimbursement approval. This study aimed to review the extent of subsequent literature documenting improvements in OS and QoL for cancer drug indications where no such evidence existed at the time of reimbursement approval.MethodsDrug indications with claims of added therapeutical value but a lack of evidence on OS and QoL that were reimbursed between 2010 and 2020 in Sweden were included for review. Searches were conducted in PubMed and ClinicalTrial.gov for randomized controlled trials examining OS and QoL.ResultsOf the 22 included drug indications, seven were found to have at least one trial with conclusive evidence of improvements in OS or QoL after a mean follow-up of 6.6 years. The remaining 15 drug indications either lacked subsequent randomized controlled trial data on OS or QoL (n = 6) or showed no statistically significant improvements (n = 9). Only one drug demonstrated evidence of improvement in both OS and QoL for its indication.ConclusionsA considerable share of reimbursed cancer drug indications continue to lack evidence of improvement in both OS and QoL. With limited healthcare resources and an increasing cancer burden, third-party payers have strong incentives to require additional post-reimbursement data to confirm any improvements in OS and QoL.

Place, publisher, year, edition, pages
Springer, 2023
Keywords
renal-cell carcinoma, european medicines agency, early breast-cancer, clinical benefit, lung-cancer, phase-III, end-points, open-label, everolimus, outcomes
National Category
Cancer and Oncology Health Care Service and Management, Health Policy and Services and Health Economy
Research subject
Economics
Identifiers
urn:nbn:se:kau:diva-96400 (URN)10.1007/s40261-023-01285-4 (DOI)001039851200001 ()37505421 (PubMedID)2-s2.0-85169757424 (Scopus ID)
Funder
The Jan Wallander and Tom Hedelius Foundation, P21-0018University of Gothenburg
Available from: 2023-08-17 Created: 2023-08-17 Last updated: 2023-09-19Bibliographically approved
Rahnert, K. & Jakobsson, N. (2023). Dokumentkamera eller skrivplatta 2.0: Har valet av presentationsverktyg betydelse för studenters lärande?. In: Jakobsson, Niklas; Vikström, Carina (Ed.), Bidrag från universitetspedagogisk konferens 2022: (pp. 39-48). Karlstad: Karlstads universitet
Open this publication in new window or tab >>Dokumentkamera eller skrivplatta 2.0: Har valet av presentationsverktyg betydelse för studenters lärande?
2023 (Swedish)In: Bidrag från universitetspedagogisk konferens 2022 / [ed] Jakobsson, Niklas; Vikström, Carina, Karlstad: Karlstads universitet, 2023, p. 39-48Chapter in book (Refereed)
Abstract [sv]

I en tidigare studie (Rahnert, 2022a) har distansundervisningens utmaningar med att presentera exempel eller övningar på elektroniska motsvarigheter till en whiteboardtavla belysts. I två synkrona redovisningskurser undersöktes om studenters upplevda lärande underlättas när bokföringsövningar presenteras med hjälp av en dokumentkamera som synliggör lärarens hand och det läraren skriver, eller en skrivplatta som enbart synliggör det läraren skriver. Studien visade att dokumentkameran underlättar studenters upplevda lärande avsevärt mer än skrivplattan.Denna studie bygger vidare på den tidigare genom att undersöka huruvida val av presentationsverktyg har betydelse för redovisningsstudenters faktiska lärande. I ett experiment fick slumpmässigt valda studenter i en kurs i grundläggande redovisning antingen se en övning som presenterades med hjälp av en dokumentkamera (lärarens hand synlig) eller en skrivplatta (lärarens hand inte synlig). Studenters lärande mättes med hjälp av tester före och efter övningen (pre- och post-tester). Resultaten visar att den genomsnittliga andelen korrekta svar ökade något mer från pre- till post-testerna för de studenter som hade sett övningen som presenterades med hjälp av dokumentkameran. Dock var skillnaderna mellan grupperna inte statistiskt signifikanta, varför försiktighet med att argumentera för dokumentkameran bör iakttas.

Place, publisher, year, edition, pages
Karlstad: Karlstads universitet, 2023
Series
Utveckling av undervisning och examination i högre utbildning: utgiven av Universitetspedagogiska enheten vid Karlstads universitet ; 2023:1
National Category
Pedagogy
Research subject
Education
Identifiers
urn:nbn:se:kau:diva-94521 (URN)978-91-7867-404-6 (ISBN)978-91-7867-405-3 (ISBN)
Available from: 2023-09-28 Created: 2023-09-28 Last updated: 2023-12-07Bibliographically approved
Svensson, M., Strand, G. C., Bonander, C., Johansson, N. & Jakobsson, N. (2023). Measurement and Analysis of Health-Related Quality of Life Data in Cancer Drug Trials: A Review of Post-Reimbursement Data. Value in Health, 26(6), Article ID S353.
Open this publication in new window or tab >>Measurement and Analysis of Health-Related Quality of Life Data in Cancer Drug Trials: A Review of Post-Reimbursement Data
Show others...
2023 (English)In: Value in Health, ISSN 1098-3015, E-ISSN 1524-4733, Vol. 26, no 6, article id S353Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Elsevier, 2023
National Category
Cancer and Oncology Public Health, Global Health, Social Medicine and Epidemiology
Research subject
Economics
Identifiers
urn:nbn:se:kau:diva-96581 (URN)10.1016/j.jval.2023.03.2763 (DOI)001031473302276 ()
Available from: 2023-09-04 Created: 2023-09-04 Last updated: 2023-09-04Bibliographically approved
Störe, S. J., Norell-Clarke, A. & Jakobsson, N. (2023). Sleep researchers' rankings of sleep journals. Journal of Sleep Research, 32(3), Article ID e13756.
Open this publication in new window or tab >>Sleep researchers' rankings of sleep journals
2023 (English)In: Journal of Sleep Research, ISSN 0962-1105, E-ISSN 1365-2869, Vol. 32, no 3, article id e13756Article in journal (Refereed) Published
Abstract [en]

The impact factor is used to rank the quality of scientific journals but has been criticised for a number of reasons. The aim of the study was to investigate sleep researchers' perceptions of sleep journals to determine whether subjective rankings of journals were in line with the journals' impact factors. Clarivate's Journal Citation Reports website was used to identify journals containing the words 'sleep' or 'dream' in the titles with an impact factor since 2018, resulting in 12 journals. A survey including questions about how the respondent would rank these journals (e.g., three most prestigious journals) was developed. A total of 122 sleep researchers completed the survey. Sleep, Sleep Medicine Reviews and Journal of Sleep Research were ranked as the three most prestigious sleep journals, in line with the impact factors of the journals. For the rest of the journals, the subjective rankings and impact factors did not correspond as much.

Place, publisher, year, edition, pages
John Wiley & Sons, 2023
Keywords
impact factor, sleep journal, survey
National Category
Psychology
Research subject
Psychology
Identifiers
urn:nbn:se:kau:diva-92562 (URN)10.1111/jsr.13756 (DOI)000877873900001 ()36316796 (PubMedID)2-s2.0-85141431569 (Scopus ID)
Available from: 2022-11-29 Created: 2022-11-29 Last updated: 2023-06-12Bibliographically approved
Ekman, M. & Jakobsson, N. (2023). The impact of earlier pub closing hours on emergency calls to the police during the COVID-19 pandemic in Sweden. Addiction Research and Theory
Open this publication in new window or tab >>The impact of earlier pub closing hours on emergency calls to the police during the COVID-19 pandemic in Sweden
2023 (English)In: Addiction Research and Theory, ISSN 1606-6359, E-ISSN 1476-7392Article in journal (Refereed) Epub ahead of print
Abstract [en]

On 20 November 2020, the government of Sweden banned on-premise alcohol sales after 10:30 p.m. and then after 8 p.m. on December 24. This study aims to estimate the impact of earlier pub closing hours on emergency calls to the police. We use a quasi-experimental hybrid differences-in-differences design, drawing on data for emergency calls in Sweden. The primary outcome measure is the daily number of emergency calls to the police in Sweden 70 days before the intervention and 70 days after the intervention. The primary control series is the daily number of emergency calls to the police in Sweden during the preceding year, 70 days before the intervention and 70 days after the intervention. We fail to find an effect on daily emergency calls, or nighttime emergency calls to the police, from the restrictions on the sale of alcohol. There is, however, some evidence indicating that weekend emergency calls may have been affected, but that potential effect does not translate into an overall effect. While our study is limited in its focus, it contributes to using a wide range of time windows and a large geographical area (the whole of Sweden) to inform on displacement effects, as well as in considering a broader set of robustness checks. We suggest that our results and future work should be seen in light of our limitations and our contribution, respectively.

Place, publisher, year, edition, pages
Taylor & Francis, 2023
Keywords
Alcohol policy, closing hours, natural experiments, crime
National Category
Economics
Research subject
Business Administration
Identifiers
urn:nbn:se:kau:diva-96104 (URN)10.1080/16066359.2023.2228682 (DOI)001018035000001 ()2-s2.0-85163613229 (Scopus ID)
Available from: 2023-07-13 Created: 2023-07-13 Last updated: 2023-08-09Bibliographically approved
Bonander, C., Ekman, M. & Jakobsson, N. (2023). When do default nudges work?. Oxford Open Economics, 2, Article ID odad094.
Open this publication in new window or tab >>When do default nudges work?
2023 (English)In: Oxford Open Economics, E-ISSN 2752-5074, Vol. 2, article id odad094Article in journal (Refereed) Published
Abstract [en]

Nudging is a burgeoning topic in science and in policy, but evidence on the effectiveness of nudges among differentially incentivized groups is lacking. This paper exploits regional variations in the rollout of the Covid-19 vaccine in Sweden to examine the effect of a nudge on groups whose intrinsic incentives are different: 16- to 17-year-olds, for whom Covid-19 is not dangerous, and 50- to 59-year-olds, who face a substantial risk of death or severe disease. We find a significantly stronger response in the younger group compared with the older (11.7 vs 3.6 percentage point increase in our study period), consistent with the theory that nudges are more effective for choices that are not meaningful to the individual.

Place, publisher, year, edition, pages
Oxford University Press, 2023
Keywords
behavioral intervention, default, decision-making, nudge, pre-booked
National Category
Economics
Research subject
Economics
Identifiers
urn:nbn:se:kau:diva-98394 (URN)10.1093/ooec/odad094 (DOI)
Available from: 2024-02-07 Created: 2024-02-07 Last updated: 2024-02-08Bibliographically approved
Chauca Strand, G., Bonander, C., Jakobsson, N., Johansson, N. & Svensson, M. (2022). Assessment of the clinical and cost-effectiveness evidence in the reimbursement decisions of new cancer drugs. ESMO Open, 7(5), Article ID 100569.
Open this publication in new window or tab >>Assessment of the clinical and cost-effectiveness evidence in the reimbursement decisions of new cancer drugs
Show others...
2022 (English)In: ESMO Open, E-ISSN 2059-7029, Vol. 7, no 5, article id 100569Article in journal (Refereed) Published
Abstract [en]

Background: This study aimed to describe the clinical and cost-effectiveness evidence supporting reimbursementdecisions of new cancer drugs and analyze the influence of trial characteristics and the cost per quality-adjusted lifeyears (QALYs) on the likelihood of reimbursement in Sweden.Patients and methods: Data were extracted from all appraisal dossiers for new cancer drugs seeking reimbursement inSweden and claiming added therapeutical value between the years 2010 and 2020. The data were analyzed usingdescriptive statistics, and logistic regression models were also used with the cost per QALY, study design,comparator, and evidence on final outcomes in the clinical trials as predictors of reimbursement.Results: All 60 included appraisals were based on trial evidence that assessed at least one final outcome (overallsurvival [OS] or quality of life [QoL]), although rarely as a primary outcome. Of the appraisals with a final decision(n ¼ 58), 79% were approved for reimbursement. Among the reimbursed drugs, only half had trial evidencedemonstrating improved OS or QoL. Only one drug had trial evidence supporting improvements in both OS andQoL. The average cost per QALY for reimbursed cancer drugs was estimated to be 748 560 SEK (V73 583). A highercost per QALY was found to decrease the likelihood of reimbursement by 9.4% for every 100 000 SEK (V9830)higher cost per QALY (P ¼ 0.03). For cost-effectiveness models without direct evidence of improvements in finaloutcomes, a larger QALY gain was observed compared with those with evidence mainly relying on intermediate andsurrogate outcomes.Conclusions: There are substantial uncertainties in the clinical and cost-effectiveness evidence underlyingreimbursement decisions of new cancer drugs. Decision makers should be cautious of the limited evidence onpatient-centered outcomes and the implications of allocating resources to expensive treatments with uncertainvalue for money.

Place, publisher, year, edition, pages
Elsevier, 2022
Keywords
reimbursement, health technology assessment, decision making, cancer drugs
National Category
Economics and Business Health Care Service and Management, Health Policy and Services and Health Economy
Identifiers
urn:nbn:se:kau:diva-91815 (URN)10.1016/j.esmoop.2022.100569 (DOI)000861347400004 ()36037568 (PubMedID)2-s2.0-85136473924 (Scopus ID)
Funder
The Jan Wallander and Tom Hedelius Foundation, P21-0018Tore Browaldhs stiftelse
Available from: 2022-09-08 Created: 2022-09-08 Last updated: 2022-10-27Bibliographically approved
Jakobsson, N. & Vikström, C. (Eds.). (2022). Bidrag från universitetspedagogisk konferens 2021. Karlstad: Karlstads universitet
Open this publication in new window or tab >>Bidrag från universitetspedagogisk konferens 2021
2022 (Swedish)Collection (editor) (Other academic)
Abstract [sv]

I föreliggande rapport kan du ta del av åtta olika utvecklingsprojekt inom undervisning och examination vid Karlstads universitet. Samtliga bidrag i rapporten har utvecklats från projekt som presenterades vid enhetens universitetsgemensamma konferens 2021, med temat Redefining Learning Spaces. Naturligt nog handlade många presentationer just om hur man behövt omdefiniera eller omvandla sin undervisning på olika sätt till följd av Covid 19-pandemin, men som vanligt presenterades även andra utvecklingsarbeten inom högskolepedagogik. 

Det handlar bland annat om den nya modellen för universitetslärares kompetensutveckling och behörighetsprövning som införts vid Karlstads universitet, eller hur en omdefiniering av lärandemiljöer och införandet av nya digitala metoder kan underlätta undervisningen för förstaårsstudenter på matematik. Du kan också läsa om hur användandet av en skrivplatta tycks underlätta ekonomistudenters upplevda lärande jämfört med vad en dokumentkamera gör, eller hur seniora psykologstudenter har stöttat förstaårsstudenter i att utveckla och träna färdigheter och förmågor som kan underlätta övergången till högre utbildning.

Publicerade texter i rapportserien kan ligga till grund för pedagogisk meritering vid ansökan om att bli meriterad eller excellent inom undervisning och examination vid Karlstads universitet.

Place, publisher, year, edition, pages
Karlstad: Karlstads universitet, 2022. p. 146
Series
Utveckling av undervisning och examination i högre utbildning: utgiven av Universitetspedagogiska enheten vid Karlstads universitet ; 2022:1
National Category
Educational Sciences
Identifiers
urn:nbn:se:kau:diva-91760 (URN)978-91-7867-297-4 (ISBN)978-91-7867-308-7 (ISBN)
Available from: 2022-09-08 Created: 2022-09-08 Last updated: 2023-09-20Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0002-7143-8793

Search in DiVA

Show all publications